Abbott Up 7.7% Post Q2 Earnings: Should You Buy ABT Stock?

After several quarters of margin-related hurdles, it seems Abbott (ABT) has finally combated this industry-wide challenge. The company’s second-quarter results reflected strong margin recovery, significantly raising investors’ optimism.Shares of this MedTech giant have risen 7.7% since its second-quarter earnings release on Jul 18 compared with the broader industry’s 3.2% increase. The stock has also outperformed the Medical sector’s 2% rise. The S&P 500, in contrast, declined 3.8% in this period.Abbott Out ...